Home › Idiopathic Thrombocytopenic Purpura › Illinois
Idiopathic Thrombocytopenic Purpura clinical trials in Illinois
4 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in Illinois.
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
- Hope And Healing Care, Hinsdale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07421167A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- Bleeding and Clotting Disorders Institute, Peoria
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06721013A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
- The Bleeding and Clotting Disorders Institute, Peoria
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 17, 2026 · NCT07700238A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- The University of Chicago Medicine, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 1, 2026 · NCT06544499From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.